Introduction: EURO-URHIS 2 aimed to collect comparable health indicators across a large number of urban areas (UAs) across Europe and Vietnam using four data collection tools. This paper outlines the process for the selection of indicators to be collected from routinely available sources, and the piloting of the data collection tool. Methods: A long-list of indicators potentially collectable from routinely available sources was generated by the EURO-URHIS 2 consortium. Key contacts from each UA completed an e-mail survey reporting for each indicator whether it could be collected using the given definition, an alternative definition or not at all. Additionally participants listed the 20 leading causes of death for their UAs from the Eurostat 65. Results were compiled to inform indicator selection for the main data collection phase. Results: Responses were received for 25 of 28 eligible UAs. Of the 29 proposed indicators, 55.1% (n = 16) were accepted without change, 24.1% (n = 7) were re-allocated to other data collection tools and 17.2% (n = 5) were accepted after a modification of the EURO-URHIS 2 definition. Discussion: This scoping exercise and piloting phase for the 'existing data tool' for the project was useful and informative. It provided detailed information on what could be collected, and an opportunity to modify indicator definitions to maximize response rates. These results are only applicable to those UAs returning results and cannot be generalized. Detailed interrogation of definitions is essential to this sort of data collection, and the process described was designed with cross-national comparability in mind. 
Introduction
T he EURO-URHIS 2 project aims to encourage evidence-based decision-making by providing relevant information to urban health policymakers about their populations. 1 At present, a vast number of indicators are collected at the national level across the European Union [e.g. the European Community Health Indicators (ECHI 2 )], but the routine collection of sub-national data is still not commonplace. It is widely accepted in public health that social and environmental factors are important determinants of health, 3 and that urban populations experience different prevalence of diseases and exposure to risk factors than their non-urban counterparts. Therefore, urban-level indicators can be considered more relevant for urban governance because they provide data on the conditions of their populations. 2 To maximize the number of indicators that can be collected by the project, four data collection methods have been developed-a semistructured interview for urban policymakers, a population level adult postal survey, a classroom-based youth survey and a tool for the collection of routinely available data (existing data). This article focuses on the latter, in particular the development of the existing data collection tool and the piloting exercise that was completed ahead of the main data collection phase.
This development and piloting phase was conducted with three main aims. First, it was necessary to establish the optimal data collection tool for each indicator, including a long-list of those indicators for which the data could most effectively be derived from existing data sources. Second, to maximise the comparability of results, definitions needed to be established that were consistent between as many of the 43 participating urban areas (UAs) as possible. Finally, this process sought to generate a cause of death shortlist that reflected the most prominent conditions in the participating UAs. The overarching aim of this study was to create and pilot a tool that facilitated routine data collection in the study of UAs, which could also be replicated in other UAs across Europe.
Methods
This was a cross-sectional study designed for completion in 43 UAs across Europe and Vietnam. Each stage of this study was completed by key contacts for each UA from within the project consortium, either one per UA or one contact responding on behalf of all UAs in their respective country. Although data collection was due to take place in the 5 UAs that form the Merseyside region, and 10 UAs of Greater Manchester, responses were only sought from Manchester and Liverpool to prevent over-representation of UK UAs, which would be collecting many indicators from the same sources. The inclusion criterion was participation in EURO-URHIS 2, and UAs were excluded if they were outside of World Health Organisation Regional Office for Europe (WHO-EURO) jurisdiction.
Selection of existing indicator long-list
The indicator long-list for all data collection tools was generated by the EURO-URHIS 2 Project Management Group (PMG). This list comprised 45 indicators that had been identified as important to urban health during EURO-URHIS phase I, 4 as well as selected indicators defined and collected by other large scale EU projects, namely ECHI, Urban Audit 5, 6 and the European Health Interview Survey (EHIS). 7 Indicators were included in the long-list if they met any of the following criteria; considered important for European urban health, complied with the findings of EURO-URHIS 1 on suggested availability, and they were designed for the analysis work packages of the project.
Respondents were then required to state-on behalf of their UA(s)-whether each indicator would be best collected using survey data, policymakers' interview or through existing data collection, or a combination of these tools. Those indicators identified as suitable for existing data collection by >1 respondent were included on the long-list. This was a low entry criterion, but the piloting phase was designed to consider the feasibility of all indicators that could potentially be collected from routine sources and this lower limit addressed selection bias.
Development of data collection tool and piloting
A data collection tool was developed to include all of the indicators proposed for routine data collection. To aide comparability with other EU projects, definitions of indicators were taken from EHIS and ECHI where possible, as well as those previously defined by EURO-URHIS I, which itself utilised definitions from other health indicator projects. 4 The data collection tool, for each indicator, provided the indicator name, definition and empty tables displaying the data requirements to complete each indicator. A separate piloting questionnaire was also sent to respondents, who, for each indicator, reported whether the indicator could be collected for their UAs:
(i) Could be collected for their UA(s) using the EURO-URHIS 2 definition (ii) Could be collected for their UA(s) using an alternative definition, provided by the respondent on the piloting questionnaire (iii) Could not be collected for their UA(s) at all For the cause of death indicator, respondents were required to complete an additional task. A table was provided with the Eurostat 65 leading causes of death (COD), seeking the perceived 20 leading COD for each UA. The top 20 from all UAs would be included in the main data collection phase.
Indicators were automatically admitted into the main existing data collection phase under the following conditions: (i) If more than 20 of the 30 UAs in the project reported that they could collect the indicator using the EURO-URHIS 2 definition, (ii) If more than 20 of the 30 UAs reported that they could collect the indicator using the EURO-URHIS 2 definition or an alternative-but similar-definition, or a definition that could replace the EURO-URHIS 2 definition.
Indicators which could be collected using the EURO-URHIS 2 or an alternative definition in <10 UAs in the project were automatically excluded. For those which could be collected in between 11 and 19 UAs, the PMG decided whether each indicators importance to urban health meant that it should be collected where available. The final decisions were presented to the project steering group for ratification.
Results

Selection of existing indicator long-list
In total 29 indicators were selected to go through to the piloting stage, based on those identified by UA contacts as most optimally collected using existing data sources (Appendix 1).
Selection of routinely available indicators
Responses were received for 25 out of the 28 UAs participating in EURO-URHIS 2 after exclusion criteria were applied (with no 24 .1% (n = 7) were re-allocated to other data collection tools, and 17.2% (n = 5) were accepted after a modification of the EURO-URHIS 2 definition to maximize the number of UAs able to collect it.
The remaining indicator (cause of death) was accepted based on the results of the process to determine the leading COD in participating UAs. Table 2 shows the 20 leading causes from the Eurostat 65 (outlined by ECHI 8 ) as reported across the 25 UAs. The top 20 from this list were selected for data collection, alongside six additional leading cause of death categories from the Global Burden of Disease estimates for Europe. 9 These were infectious diseases, intestinal infections, HIV/AIDs, tuberculosis, prematurity and low birth weight and Alzheimer and other dementias.
Discussion
This article has presented a methodology for the collection of comparable urban health indicators from existing sources that could be applied beyond the participating UAs. The process entailed the selection of a long-list of desirable indicators and the completion of a pilot phase where the success of collecting each indicator can be realistically assessed. These preliminary stages facilitated the main data collection phase, which was completed by all project partners. The methodology represents a structured scoping study that established what could be achieved within the parameters of the project. This could be adapted to other projects in a variety of settings to assist with the collection of a comprehensive set of indicators. This process deviated from other projects in that it aimed to collect indicators using several data collection tools, including population surveys and interviews with key contacts. Therefore indicators were not necessarily excluded from the study based on availability, as demonstrated by those indicators moved to the semi-structured interviews for policy-makers.
To achieve a maximum response rate on as many indicators as possible, it was agreed for certain indicators to allow UAs from individual countries to collect data to a slightly amended definition (such as total fertility rate for the Slovenian UAs of Ljubljana and Maribor, which included females aged up to 49 years rather than 45 years), or for a larger sub-national populations where city level were unavailable (such as Troms county data for the Tromsø UA). These deviations will be reported when the project results are published. One strength of this process was that it was not deemed necessary for all UAs to collect all indicators, thus increasing the number of UAs able to participate. Had the methodology been less malleable to local conditions and data availability, then only a small number of indicators would have remained. The Turkish UAs of Ankara and Izmir in particular could provide little UA-level data. Had the cut-off for acceptance been <100%, very few indicators would have remained due to this. Instead, UAs were only required to collect the accepted indicators that they had stated were available during the piloting phase. As urban-level indicators are not as routinely available as national-level indicators, such concessions need to be made to facilitate inclusion. At the same time, highlighting where data are unavailable at the urban level is also a finding that can be reported and used to generate recommendations for future urban health indicators.
This study did have limitations. With the relatively small sample of 30 UAs, the contribution of the five UAs who did not complete the questionnaire could have had a major impact on the indicators selected for the main phase. The exclusion of the Vietnamese UAswhich was determined by their position outside of WHO-EURO, as well as issues with accessing routine data sources in these UAs-means that we were unable to test the applicability of the piloting tool outside of Europe.
The indicators selected for the project do not represent an exhaustive list, but the collective priorities of the EURO-URHIS 2 consortium. Those included were heavily influenced by EURO-URHIS 1 and other European projects collecting health indicators. It is possible that other important indicators may have been missed, or discounted due to perceived unavailability in the early stages of the project. Similarly, some routinely available indicators may have been wrongly allocated during the pre-piloting indicator selection task.
The selection of cause of death categories could have been collected by ranking each disease and injury condition from 1 to 20, rather than returning a top 20 with no order. However, the method used in this study prevented over-representation of illnesses that were considered important in only one or two UAs. The list of categories included both groups of conditions and individual conditions (e.g. all malignant neoplasms and site-specific neoplasms), with groups of conditions more likely to feature in the top 20.
While EURO-URHIS 2 benefits from having other sources of data collection, this will not be the case for all projects. In this study, alcohol consumption and smoking prevalence were simply moved to the adult and youth population tools, but what if survey data are beyond the scope of such initiatives? Future work should consider what can be done with those indicators found to be widely unavailable.
These limitations aside, this piloting process facilitated the collection of existing data in 43 UAs as part of the EURO-URHIS 2 project. The methodology can be easily replicated and adapted for use in other large-scale projects, especially those looking at international comparisons. 
